ID	Description	NES	pvalue	p.adjust	GeneRatio	BgRatio	geneID	geneName	Count
KEGG_hsa05416	Viral myocarditis	-7.22009074993886	0.00960919392775914	0.296956352453066	5/307	56/13181	6444/2534/27/1604/3134	SGCD/FYN/ABL2/CD55/HLA-F	5
KEGG_hsa04924	Renin secretion	-7.59575238504434	0.0175621606991509	0.296956352453066	5/307	65/13181	134/3710/1909/3778/779	ADORA1/ITPR3/EDNRA/KCNMA1/CACNA1S	5
KEGG_hsa00230	Purine metabolism	-8.67002398563803	0.0195504075133632	0.296956352453066	7/307	117/13181	353/374659/5167/11164/53343/27115/84284	APRT/HDDC3/ENPP1/NUDT5/NUDT9/PDE7B/NTPCR	7
KEGG_hsa04066	HIF-1 signaling pathway	-7.61394876939284	0.0280522498524414	0.296956352453066	6/307	99/13181	2872/7099/596/284/3460/112399	MKNK2/TLR4/BCL2/ANGPT1/IFNGR2/EGLN3	6
KEGG_hsa05152	Tuberculosis	-9.14717923322801	0.0348207649429594	0.296956352453066	8/307	161/13181	5869/317/7099/5603/596/64127/3460/10892	RAB5B/APAF1/TLR4/MAPK13/BCL2/NOD2/IFNGR2/MALT1	8
KEGG_hsa05202	Transcriptional misregulation in cancer	-10.0965879759901	0.0348207649429594	0.296956352453066	8/307	161/13181	2115/6257/861/4066/51804/84444/466/8148	ETV1/RXRB/RUNX1/LYL1/SIX4/DOT1L/ATF1/TAF15	8
KEGG_hsa04725	Cholinergic synapse	-7.25315667192528	0.0404033617580844	0.296956352453066	6/307	108/13181	3786/3710/6572/779/596/2534	KCNQ3/ITPR3/SLC18A3/CACNA1S/BCL2/FYN	6
KEGG_hsa00760	Nicotinate and nicotinamide metabolism	-4.76798506728402	0.0440108519900078	0.296956352453066	3/307	34/13181	5167/23530/23409	ENPP1/NNT/SIRT4	3
KEGG_hsa04071	Sphingolipid signaling pathway	-7.29652229880689	0.0502909964834851	0.301208807811505	6/307	114/13181	134/5603/596/2534/91012/6093	ADORA1/MAPK13/BCL2/FYN/CERS5/ROCK1	6
KEGG_hsa00830	Retinol metabolism	-6.2627011653997	0.0535198823115212	0.301208807811505	4/307	61/13181	8694/157506/127/79799	DGAT1/RDH10/ADH4/UGT2A3	4
KEGG_hsa05222	Small cell lung cancer	-7.06715454040894	0.0566443172866957	0.301208807811505	5/307	89/13181	6257/5925/317/596/3915	RXRB/RB1/APAF1/BCL2/LAMC1	5
KEGG_hsa04660	T cell receptor signaling pathway	-6.57040453651434	0.0734023846403449	0.306647594612241	5/307	96/13181	1739/1493/5603/2534/10892	DLG1/CTLA4/MAPK13/FYN/MALT1	5
KEGG_hsa00071	Fatty acid degradation	-5.70850771524604	0.073857611398743	0.306647594612241	3/307	42/13181	1375/127/3033	CPT1B/ADH4/HADH	3
KEGG_hsa00532	Glycosaminoglycan biosynthesis	-5.16500923795603	0.078021744310637	0.306647594612241	2/307	20/13181	55790/51363	CSGALNACT1/CHST15	2
KEGG_hsa05223	Non-small cell lung cancer	-6.09555109342236	0.0802400996264154	0.306647594612241	4/307	70/13181	6257/5925/3082/3718	RXRB/RB1/HGF/JAK3	4
KEGG_hsa00270	Cysteine and methionine metabolism	-4.94056097742514	0.0868571342682275	0.306647594612241	3/307	45/13181	7263/64902/1491	TST/AGXT2/CTH	3
KEGG_hsa04621	NOD-like receptor signaling pathway	-9.69918036572784	0.0890194137679987	0.306647594612241	7/307	164/13181	3710/7128/7099/5603/596/64127/114769	ITPR3/TNFAIP3/TLR4/MAPK13/BCL2/NOD2/CARD16	7
KEGG_hsa04659	Th17 cell differentiation	-7.96895277309817	0.0955030592041872	0.322248119667696	5/307	104/13181	6257/861/3718/5603/3460	RXRB/RUNX1/JAK3/MAPK13/IFNGR2	5
KEGG_hsa05145	Toxoplasmosis	-7.78860626780423	0.0984801312146796	0.326491234168642	5/307	105/13181	7099/5603/596/3915/3460	TLR4/MAPK13/BCL2/LAMC1/IFNGR2	5
KEGG_hsa05323	Rheumatoid arthritis	-6.17730579355323	0.104786693083208	0.326491234168642	4/307	77/13181	7099/1493/1435/284	TLR4/CTLA4/CSF1/ANGPT1	4
KEGG_hsa00650	Butanoate metabolism	-5.44594484200697	0.122031640462293	0.345867855903694	2/307	26/13181	3033/7915	HADH/ALDH5A1	2
KEGG_hsa04215	Apoptosis	-3.66832103034305	0.129857121502437	0.345867855903694	2/307	27/13181	317/596	APAF1/BCL2	2
KEGG_hsa00750	Vitamin B6 metabolism	-2.5293912094284	0.131881363452892	0.345867855903694	1/307	6/13181	55163	PNPO	1
KEGG_hsa04630	JAK-STAT signaling pathway	-7.92898375076359	0.134975662863292	0.353295521436344	6/307	149/13181	3718/596/5156/11009/3460/53342	JAK3/BCL2/PDGFRA/IL24/IFNGR2/IL17D	6
KEGG_hsa01212	Fatty acid metabolism	-5.79221927615974	0.136226346566909	0.35587813017867	3/307	55/13181	3295/1375/3033	HSD17B4/CPT1B/HADH	3
KEGG_hsa05161	Hepatitis B	-7.68115046995498	0.138039409053767	0.3585301028988	6/307	150/13181	5925/3718/317/7099/5603/596	RB1/JAK3/APAF1/TLR4/MAPK13/BCL2	6
KEGG_hsa04530	Tight junction	-9.22074862702917	0.144263836913392	0.358778864081208	6/307	152/13181	1739/861/54566/84552/5562/6093	DLG1/RUNX1/EPB41L4B/PARD6G/PRKAA1/ROCK1	6
KEGG_hsa00310	Lysine degradation	-5.53672269083259	0.147058235422769	0.358778864081208	3/307	57/13181	55217/84444/3033	TMLHE/DOT1L/HADH	3
KEGG_hsa04122	Sulfur relay system	-2.65122486667562	0.152110010239986	0.358778864081208	1/307	7/13181	7263	TST	1
KEGG_hsa04217	Necroptosis	-7.75649240471778	0.15578972593704	0.362702159867236	5/307	122/13181	7128/3718/7099/596/3460	TNFAIP3/JAK3/TLR4/BCL2/IFNGR2	5
KEGG_hsa04022	cGMP-PKG signaling pathway	-8.31207617303556	0.160372167536646	0.370094465326666	6/307	157/13181	134/3710/1909/3778/779/6093	ADORA1/ITPR3/EDNRA/KCNMA1/CACNA1S/ROCK1	6
KEGG_hsa05231	Choline metabolism in cancer	-5.70555907904352	0.162457689538243	0.370094465326666	4/307	91/13181	1606/1120/5156/8936	DGKA/CHKB/PDGFRA/WASF1	4
KEGG_hsa04270	Vascular smooth muscle contraction	-7.77482593208411	0.167097504013432	0.370094465326666	5/307	125/13181	3710/1909/3778/779/6093	ITPR3/EDNRA/KCNMA1/CACNA1S/ROCK1	5
KEGG_hsa05162	Measles	-7.57086138587955	0.167097504013432	0.370094465326666	5/307	125/13181	7128/3718/317/7099/596	TNFAIP3/JAK3/APAF1/TLR4/BCL2	5
KEGG_hsa00740	Riboflavin metabolism	-2.60344873970846	0.171868794728852	0.370094465326666	1/307	8/13181	5167	ENPP1	1
KEGG_hsa00920	Sulfur metabolism	-2.65122486667562	0.171868794728852	0.370094465326666	1/307	8/13181	7263	TST	1
KEGG_hsa04064	NF-kappa B signaling pathway	-7.07594467198328	0.180704012005875	0.384907045840755	4/307	95/13181	7128/7099/596/10892	TNFAIP3/TLR4/BCL2/MALT1	4
KEGG_hsa04612	Antigen processing and presentation	-5.32762325675794	0.181085260792024	0.384907045840755	3/307	63/13181	10437/3821/3134	IFI30/KLRC1/HLA-F	3
KEGG_hsa05321	Inflammatory bowel disease	-5.32562857070264	0.181085260792024	0.384907045840755	3/307	63/13181	7099/64127/3460	TLR4/NOD2/IFNGR2	3
KEGG_hsa00250	Alanine, aspartate and glutamate metabolism	-5.34684697874088	0.18728391131746	0.384907045840755	2/307	34/13181	64902/7915	AGXT2/ALDH5A1	2
KEGG_hsa04922	Glucagon signaling pathway	-7.58405972458303	0.190073565856008	0.384907045840755	4/307	97/13181	3710/200186/1375/5562	ITPR3/CRTC2/CPT1B/PRKAA1	4
KEGG_hsa05216	Thyroid cancer	-3.54094201933189	0.195765683298546	0.392113136829777	2/307	35/13181	6257/10342	RXRB/TFG	2
KEGG_hsa04920	Adipocytokine signaling pathway	-6.40289058307938	0.204835065063629	0.398181456851992	3/307	67/13181	6257/1375/5562	RXRB/CPT1B/PRKAA1	3
KEGG_hsa04931	Insulin resistance	-7.16739834297416	0.209255174311234	0.398181456851992	4/307	101/13181	200186/11000/1375/5562	CRTC2/SLC27A3/CPT1B/PRKAA1	4
KEGG_hsa00260	Glycine, serine and threonine metabolism	-3.80123739907142	0.212863142470211	0.402439713954902	2/307	37/13181	64902/1491	AGXT2/CTH	2
KEGG_hsa04625	C-type lectin receptor signaling pathway	-6.62053022766276	0.214135393698762	0.404561332454004	4/307	102/13181	3710/5603/10892/53342	ITPR3/MAPK13/MALT1/IL17D	4
KEGG_hsa04360	Axon guidance	-6.94254245727115	0.216611097758201	0.408665863930098	6/307	173/13181	6092/2534/5362/84552/6093/8633	ROBO2/FYN/PLXNA2/PARD6G/ROCK1/UNC5C	6
KEGG_hsa05140	Leishmaniasis	-5.54654293537722	0.216967822431888	0.409052621871588	3/307	69/13181	7099/5603/3460	TLR4/MAPK13/IFNGR2	3
KEGG_hsa05332	Graft-versus-host disease	-4.38250746538082	0.221465603219749	0.412220049334707	2/307	38/13181	3821/3134	KLRC1/HLA-F	2
KEGG_hsa05218	Melanoma	-5.35353798854795	0.223089959273925	0.412220049334707	3/307	70/13181	5925/3082/5156	RB1/HGF/PDGFRA	3
KEGG_hsa00380	Tryptophan metabolism	-4.29152332714165	0.230095536452932	0.413558377518069	2/307	39/13181	8942/3033	KYNU/HADH	2
KEGG_hsa01521	EGFR tyrosine kinase inhibitor resistance	-5.31745510853854	0.241650474710975	0.421005098719819	3/307	73/13181	3082/596/5156	HGF/BCL2/PDGFRA	3
KEGG_hsa04141	Protein processing in endoplasmic reticulum	-7.22354674361254	0.245183704720105	0.421005098719819	5/307	144/13181	10961/596/10956/5611/10484	ERP29/BCL2/OS9/DNAJC3/SEC23A	5
KEGG_hsa04921	Oxytocin signaling pathway	-7.78314499963478	0.245183704720105	0.421005098719819	5/307	144/13181	3710/779/5607/5562/6093	ITPR3/CACNA1S/MAP2K5/PRKAA1/ROCK1	5
KEGG_hsa03030	DNA replication	-2.57283911223424	0.246419156446541	0.421005098719819	1/307	12/13181	29935	RPA4	1
KEGG_hsa03430	Mismatch repair	-2.57283911223424	0.246419156446541	0.421005098719819	1/307	12/13181	29935	RPA4	1
KEGG_hsa04668	TNF signaling pathway	-6.89792732275136	0.249105764555227	0.423715546524221	4/307	109/13181	7128/5603/1435/64127	TNFAIP3/MAPK13/CSF1/NOD2	4
KEGG_hsa00450	Selenocompound metabolism	-2.25882545267613	0.263986877531735	0.430816357037262	1/307	13/13181	1491	CTH	1
KEGG_hsa00730	Thiamine metabolism	-2.87110743035328	0.263986877531735	0.430816357037262	1/307	13/13181	84284	NTPCR	1
KEGG_hsa04722	Neurotrophin signaling pathway	-6.60567261564425	0.264457852619751	0.431319866865635	4/307	112/13181	4909/5603/596/5607	NTF4/MAPK13/BCL2/MAP2K5	4
KEGG_hsa05144	Malaria	-4.83003710035506	0.273458863864121	0.442789848034637	2/307	44/13181	3082/7099	HGF/TLR4	2
KEGG_hsa04970	Salivary secretion	-6.5655072036806	0.279437340654786	0.445341115791981	3/307	79/13181	3710/3778/6558	ITPR3/KCNMA1/SLC12A2	3
KEGG_hsa05320	Autoimmune thyroid disease	-4.32314112883915	0.282138014077884	0.445341970699049	2/307	45/13181	1493/3134	CTLA4/HLA-F	2
KEGG_hsa04540	Gap junction	-5.17511095360506	0.285795731862665	0.450587890702775	3/307	80/13181	3710/5156/5607	ITPR3/PDGFRA/MAP2K5	3
KEGG_hsa05164	Influenza A	-7.34321430333728	0.289601717754578	0.45632158449231	5/307	154/13181	317/7099/23430/3460/5611	APAF1/TLR4/TPSD1/IFNGR2/DNAJC3	5
KEGG_hsa04380	Osteoclast differentiation	-5.89909423029834	0.29040912518119	0.456339438771794	4/307	117/13181	5603/1435/2534/3460	MAPK13/CSF1/FYN/IFNGR2	4
KEGG_hsa04146	Peroxisome	-5.19573186154645	0.292165833364977	0.456339438771794	3/307	81/13181	25824/3295/84188	PRDX5/HSD17B4/FAR1	3
KEGG_hsa04611	Platelet activation	-6.25240276092834	0.295643390170262	0.456339438771794	4/307	118/13181	3710/5603/2534/6093	ITPR3/MAPK13/FYN/ROCK1	4
KEGG_hsa00604	Glycosphingolipid biosynthesis	-2.28700489197515	0.297907052017195	0.456339438771794	1/307	15/13181	2583	B4GALNT1	1
KEGG_hsa00280	Valine, leucine and isoleucine degradation	-4.27783350193238	0.299465496874797	0.457946102991748	2/307	47/13181	64902/3033	AGXT2/HADH	2
KEGG_hsa00564	Glycerophospholipid metabolism	-5.03759859620414	0.30493316965805	0.465778937902608	3/307	83/13181	1606/1120/10908	DGKA/CHKB/PNPLA6	3
KEGG_hsa04512	ECM-receptor interaction	-6.03612520661058	0.324123089493094	0.479743941434315	3/307	86/13181	5649/3915/3161	RELN/LAMC1/HMMR	3
KEGG_hsa04657	IL-17 signaling pathway	-6.3568923517686	0.324123089493094	0.479743941434315	3/307	86/13181	7128/5603/53342	TNFAIP3/MAPK13/IL17D	3
KEGG_hsa04911	Insulin secretion	-5.53711197876819	0.324123089493094	0.479743941434315	3/307	86/13181	3710/3778/779	ITPR3/KCNMA1/CACNA1S	3
KEGG_hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	-5.54654293537722	0.324123089493094	0.479743941434315	3/307	86/13181	7099/5603/3460	TLR4/MAPK13/IFNGR2	3
KEGG_hsa05134	Legionellosis	-4.07387269071869	0.325318421850136	0.479743941434315	2/307	50/13181	317/7099	APAF1/TLR4	2
KEGG_hsa00120	Primary bile acid biosynthesis	-2.84288038464503	0.330268826150626	0.479743941434315	1/307	17/13181	3295	HSD17B4	1
KEGG_hsa05418	Fluid shear stress and atherosclerosis	-6.98786295456202	0.337854670722955	0.488738660983442	4/307	126/13181	5603/596/5607/5562	MAPK13/BCL2/MAP2K5/PRKAA1	4
KEGG_hsa00561	Glycerolipid metabolism	-4.40935949012272	0.342418341952895	0.488738660983442	2/307	52/13181	8694/1606	DGAT1/DGKA	2
KEGG_hsa05410	Hypertrophic cardiomyopathy	-5.93245750753422	0.343315666570804	0.488738660983442	3/307	89/13181	779/6444/5562	CACNA1S/SGCD/PRKAA1	3
KEGG_hsa00670	One carbon pool by folate	-3.06910687935531	0.345887746719735	0.488738660983442	1/307	18/13181	160428	ALDH1L2	1
KEGG_hsa04061	Viral protein interaction with cytokine and cytokine receptor	-5.28173722413011	0.349705654067622	0.493099604271082	3/307	90/13181	1435/11009/6373	CSF1/IL24/CXCL11	3
KEGG_hsa04658	Th1 and Th2 cell differentiation	-5.11316374496111	0.349705654067622	0.493099604271082	3/307	90/13181	3718/5603/3460	JAK3/MAPK13/IFNGR2	3
KEGG_hsa04912	GnRH signaling pathway	-5.39018268248363	0.349705654067622	0.493099604271082	3/307	90/13181	3710/779/5603	ITPR3/CACNA1S/MAPK13	3
KEGG_hsa04640	Hematopoietic cell lineage	-4.88638509116366	0.35608910740385	0.497264084265774	3/307	91/13181	1435/1604/4254	CSF1/CD55/KITLG	3
KEGG_hsa04972	Pancreatic secretion	-6.5655072036806	0.35608910740385	0.497264084265774	3/307	91/13181	3710/3778/6558	ITPR3/KCNMA1/SLC12A2	3
KEGG_hsa04923	Regulation of lipolysis in adipocytes	-3.68181657482012	0.359379193595241	0.497264084265774	2/307	54/13181	134/51099	ADORA1/ABHD5	2
KEGG_hsa04620	Toll-like receptor signaling pathway	-5.33044700886487	0.368830064101584	0.506812361273124	3/307	93/13181	7099/5603/6373	TLR4/MAPK13/CXCL11	3
KEGG_hsa01522	Endocrine resistance	-5.13694873294712	0.375184496175588	0.507849133188141	3/307	94/13181	5925/5603/596	RB1/MAPK13/BCL2	3
KEGG_hsa05215	Prostate cancer	-4.83745501138243	0.375184496175588	0.507849133188141	3/307	94/13181	5925/596/5156	RB1/BCL2/PDGFRA	3
KEGG_hsa00340	Histidine metabolism	-2.82907866496567	0.376044723512147	0.507849133188141	1/307	20/13181	3067	HDC	1
KEGG_hsa00982	Drug metabolism	-4.08769070685962	0.376177566386023	0.507849133188141	2/307	56/13181	127/79799	ADH4/UGT2A3	2
KEGG_hsa03013	Nucleocytoplasmic transport	-5.58307260680463	0.376177566386023	0.507849133188141	2/307	56/13181	64901/79023	RANBP17/NUP37	2
KEGG_hsa04750	Inflammatory mediator regulation of TRP channels	-5.57637621574281	0.381526251094165	0.514554663806838	3/307	95/13181	3710/5603/162514	ITPR3/MAPK13/TRPV3	3
KEGG_hsa04925	Aldosterone synthesis and secretion	-5.20732088662962	0.387853894672939	0.519002473022107	3/307	96/13181	3710/779/466	ITPR3/CACNA1S/ATF1	3
KEGG_hsa00770	Pantothenate and CoA biosynthesis	-2.60344873970846	0.390599413116415	0.519002473022107	1/307	21/13181	5167	ENPP1	1
KEGG_hsa04723	Retrograde endocannabinoid signaling	-6.37955819220903	0.390859045928943	0.519091619617946	4/307	136/13181	3710/779/5603/4731	ITPR3/CACNA1S/MAPK13/NDUFV3	4
KEGG_hsa05146	Amoebiasis	-5.9124638136468	0.400461311257261	0.531059368002742	3/307	98/13181	5869/7099/3915	RAB5B/TLR4/LAMC1	3
KEGG_hsa05142	Chagas disease	-5.54654293537722	0.406738415116851	0.535432991774917	3/307	99/13181	7099/5603/3460	TLR4/MAPK13/IFNGR2	3
KEGG_hsa00980	Metabolism of xenobiotics by cytochrome P450	-4.08769070685962	0.409205241202424	0.537630277915075	2/307	60/13181	127/79799	ADH4/UGT2A3	2
KEGG_hsa04072	Phospholipase D signaling pathway	-5.89176341891246	0.411935907537815	0.540954314038943	4/307	140/13181	1606/5156/2534/4254	DGKA/PDGFRA/FYN/KITLG	4
KEGG_hsa05130	Pathogenic Escherichia coli infection	-6.99538627554232	0.413969876201714	0.543223692203209	5/307	181/13181	7099/5603/2534/8936/6093	TLR4/MAPK13/FYN/WASF1/ROCK1	5
KEGG_hsa04932	Non-alcoholic fatty liver disease	-7.73678405123201	0.417182944970389	0.543223692203209	4/307	141/13181	5603/1347/4731/5562	MAPK13/COX7A2/NDUFV3/PRKAA1	4
KEGG_hsa03420	Nucleotide excision repair	-2.57283911223424	0.418701347328735	0.543223692203209	1/307	23/13181	29935	RPA4	1
KEGG_hsa05211	Renal cell carcinoma	-4.245042355658	0.425399220143941	0.55118121941054	2/307	62/13181	3082/112399	HGF/EGLN3	2
KEGG_hsa05226	Gastric cancer	-6.17447181335231	0.427644714526434	0.551426167747063	4/307	143/13181	6257/5925/3082/596	RXRB/RB1/HGF/BCL2	4
KEGG_hsa01524	Platinum drug resistance	-3.66832103034305	0.433409513893185	0.551426167747063	2/307	63/13181	317/596	APAF1/BCL2	2
KEGG_hsa04520	Adherens junction	-3.65576830513331	0.433409513893185	0.551426167747063	2/307	63/13181	2534/8936	FYN/WASF1	2
KEGG_hsa04929	GnRH secretion	-4.15779053074526	0.433409513893185	0.551426167747063	2/307	63/13181	3710/779	ITPR3/CACNA1S	2
KEGG_hsa04218	Cellular senescence	-6.84722834218881	0.438058236416722	0.556815184054447	4/307	145/13181	3710/5925/5603/3134	ITPR3/RB1/MAPK13/HLA-F	4
KEGG_hsa04664	Fc epsilon RI signaling pathway	-3.8930479928142	0.441359758705743	0.560219354741376	2/307	64/13181	5603/2534	MAPK13/FYN	2
KEGG_hsa04927	Cortisol synthesis and secretion	-4.15779053074526	0.441359758705743	0.560219354741376	2/307	64/13181	3710/779	ITPR3/CACNA1S	2
KEGG_hsa04928	Parathyroid hormone synthesis, secretion and action	-5.18393923466005	0.443950616464964	0.560475395119565	3/307	105/13181	3710/6257/596	ITPR3/RXRB/BCL2	3
KEGG_hsa00053	Ascorbate and aldarate metabolism	-2.68076725513855	0.445511413850604	0.560475395119565	1/307	25/13181	79799	UGT2A3	1
KEGG_hsa04115	p53 signaling pathway	-3.66832103034305	0.449248402351833	0.563598740223612	2/307	65/13181	317/596	APAF1/BCL2	2
KEGG_hsa04721	Synaptic vesicle cycle	-3.82665740606095	0.449248402351833	0.563598740223612	2/307	65/13181	6572/6507	SLC18A3/SLC1A3	2
KEGG_hsa00062	Fatty acid elongation	-2.88769778064469	0.458450604786136	0.568006815488705	1/307	26/13181	3033	HADH	1
KEGG_hsa00563	Glycosylphosphatidylinositol (GPI)-anchor biosynthesis	-2.73994309996827	0.458450604786136	0.568006815488705	1/307	26/13181	5281	PIGF	1
KEGG_hsa01040	Biosynthesis of unsaturated fatty acids	-2.84288038464503	0.458450604786136	0.568006815488705	1/307	26/13181	3295	HSD17B4	1
KEGG_hsa03022	Basal transcription factors	-2.74701439766643	0.458450604786136	0.568006815488705	1/307	26/13181	8148	TAF15	1
KEGG_hsa03440	Homologous recombination	-2.57283911223424	0.471088815681663	0.578349474989874	1/307	27/13181	29935	RPA4	1
KEGG_hsa00040	Pentose and glucuronate interconversions	-2.68076725513855	0.483433025320231	0.584455352584459	1/307	28/13181	79799	UGT2A3	1
KEGG_hsa00500	Starch and sucrose metabolism	-2.60344873970846	0.483433025320231	0.584455352584459	1/307	28/13181	5167	ENPP1	1
KEGG_hsa04392	Hippo signaling pathway	-2.68163248759657	0.483433025320231	0.584455352584459	1/307	28/13181	60485	SAV1	1
KEGG_hsa04710	Circadian rhythm	-4.34063572413182	0.483433025320231	0.584455352584459	1/307	28/13181	5562	PRKAA1	1
KEGG_hsa04152	AMPK signaling pathway	-6.45436838289302	0.486157957579113	0.587486263394571	3/307	112/13181	200186/1375/5562	CRTC2/CPT1B/PRKAA1	3
KEGG_hsa04917	Prolactin signaling pathway	-4.75767764239828	0.487720357418426	0.588582848522863	2/307	70/13181	5603/2592	MAPK13/GALT	2
KEGG_hsa04650	Natural killer cell mediated cytotoxicity	-4.79179556090627	0.492063678625739	0.592653583851097	3/307	113/13181	2534/3821/3460	FYN/KLRC1/IFNGR2	3
KEGG_hsa03320	PPAR signaling pathway	-4.2407185601537	0.495212366846594	0.592653583851097	2/307	71/13181	6257/1375	RXRB/CPT1B	2
KEGG_hsa00052	Galactose metabolism	-3.39929964429943	0.495490051187082	0.592653583851097	1/307	29/13181	2592	GALT	1
KEGG_hsa04130	SNARE interactions in vesicular transport	-2.43843261926722	0.495490051187082	0.592653583851097	1/307	29/13181	9482	STX8	1
KEGG_hsa05133	Pertussis	-4.49580744840162	0.502634615764177	0.600134155934553	2/307	72/13181	7099/5603	TLR4/MAPK13	2
KEGG_hsa04935	Growth hormone synthesis, secretion and action	-5.39018268248363	0.509577195108229	0.603081702375674	3/307	116/13181	3710/779/5603	ITPR3/CACNA1S/MAPK13	3
KEGG_hsa05214	Glioma	-3.78046382296725	0.509986281709338	0.603301016010695	2/307	73/13181	5925/5156	RB1/PDGFRA	2
KEGG_hsa00513	Various types of N-glycan biosynthesis	-2.22851701946232	0.518769037268412	0.60941234181945	1/307	31/13181	338707	B4GALNT4	1
KEGG_hsa05220	Chronic myeloid leukemia	-5.66294754731774	0.524474950728582	0.615310908252505	2/307	75/13181	5925/861	RB1/RUNX1	2
KEGG_hsa05412	Arrhythmogenic right ventricular cardiomyopathy	-3.68745208850328	0.524474950728582	0.615310908252505	2/307	75/13181	779/6444	CACNA1S/SGCD	2
KEGG_hsa00512	Mucin type O-glycan biosynthesis	-2.39832531334792	0.540977226942822	0.627570827813188	1/307	33/13181	56913	C1GALT1	1
KEGG_hsa04145	Phagosome	-5.64140814737501	0.543627069556193	0.630373582590751	3/307	122/13181	5869/7099/3134	RAB5B/TLR4/HLA-F	3
KEGG_hsa04260	Cardiac muscle contraction	-4.40048503745574	0.545662217336011	0.632189659620922	2/307	78/13181	779/1347	CACNA1S/COX7A2	2
KEGG_hsa00350	Tyrosine metabolism	-2.71297296935557	0.551695206204197	0.636444277247118	1/307	34/13181	127	ADH4	1
KEGG_hsa05340	Primary immunodeficiency	-2.38122227325096	0.551695206204197	0.636444277247118	1/307	34/13181	3718	JAK3	1
KEGG_hsa04210	Apoptosis	-5.17371746064778	0.554670289335548	0.639329243287147	3/307	124/13181	3710/317/596	ITPR3/APAF1/BCL2	3
KEGG_hsa05330	Allograft rejection	-3.28016513039503	0.562163721583775	0.645757730460101	1/307	35/13181	3134	HLA-F	1
KEGG_hsa05135	Yersinia infection	-5.47282511897808	0.57093408830955	0.654438053606525	3/307	127/13181	7099/5603/6093	TLR4/MAPK13/ROCK1	3
KEGG_hsa04910	Insulin signaling pathway	-5.97614905252531	0.581571206493255	0.661088008110545	3/307	129/13181	2872/5573/5562	MKNK2/PRKAR1A/PRKAA1	3
KEGG_hsa04962	Vasopressin-regulated water reabsorption	-2.42066928203372	0.582375378064742	0.661088008110545	1/307	37/13181	5869	RAB5B	1
KEGG_hsa04975	Fat digestion and absorption	-3.08828526705486	0.582375378064742	0.661088008110545	1/307	37/13181	8694	DGAT1	1
KEGG_hsa05110	Vibrio cholerae infection	-3.89371615146838	0.582375378064742	0.661088008110545	1/307	37/13181	6558	SLC12A2	1
KEGG_hsa04742	Taste transduction	-4.5888114741771	0.586030933988302	0.664677912508398	2/307	84/13181	3710/50836	ITPR3/TAS2R8	2
KEGG_hsa00860	Porphyrin and chlorophyll metabolism	-2.68076725513855	0.592129696303797	0.669623180048253	1/307	38/13181	79799	UGT2A3	1
KEGG_hsa05219	Bladder cancer	-2.57462628526921	0.592129696303797	0.669623180048253	1/307	38/13181	5925	RB1	1
KEGG_hsa05167	Kaposi sarcoma-associated herpesvirus infection	-6.84722834218881	0.598479233899622	0.676236384993035	4/307	178/13181	3710/5925/5603/3134	ITPR3/RB1/MAPK13/HLA-F	4
KEGG_hsa05032	Morphine addiction	-4.15612630758077	0.59888600221018	0.676412510246605	2/307	86/13181	134/27115	ADORA1/PDE7B	2
KEGG_hsa04514	Cell adhesion molecules	-5.79464082276344	0.607425611145763	0.684034195029314	3/307	134/13181	1493/1013/3134	CTLA4/CDH15/HLA-F	3
KEGG_hsa03460	Fanconi anemia pathway	-2.57283911223424	0.610962292889684	0.684034195029314	1/307	40/13181	29935	RPA4	1
KEGG_hsa04940	Type I diabetes mellitus	-3.28016513039503	0.610962292889684	0.684034195029314	1/307	40/13181	3134	HLA-F	1
KEGG_hsa04070	Phosphatidylinositol signaling system	-4.48525646302463	0.611439494856858	0.684284299765084	2/307	88/13181	3710/1606	ITPR3/DGKA	2
KEGG_hsa00190	Oxidative phosphorylation	-4.73767077171598	0.623691843000642	0.694823639970964	2/307	90/13181	1347/4731	COX7A2/NDUFV3	2
KEGG_hsa01240	Biosynthesis of cofactors	-5.14558909570186	0.627332793407068	0.696054999448837	3/307	138/13181	55163/8942/79799	PNPO/KYNU/UGT2A3	3
KEGG_hsa00514	Other types of O-glycan biosynthesis	-2.39832531334792	0.62892803362662	0.696054999448837	1/307	42/13181	56913	C1GALT1	1
KEGG_hsa04261	Adrenergic signaling in cardiomyocytes	-4.95856712303061	0.637023457400333	0.703628780993355	3/307	140/13181	779/5603/596	CACNA1S/MAPK13/BCL2	3
KEGG_hsa05414	Dilated cardiomyopathy	-3.68745208850328	0.641508119788671	0.706786224336026	2/307	93/13181	779/6444	CACNA1S/SGCD	2
KEGG_hsa04114	Oocyte meiosis	-4.59786979329393	0.653013280182111	0.717111671873481	2/307	95/13181	3710/5603	ITPR3/MAPK13	2
KEGG_hsa00520	Amino sugar and nucleotide sugar metabolism	-3.39929964429943	0.65433780148693	0.717111671873481	1/307	45/13181	2592	GALT	1
KEGG_hsa00600	Sphingolipid metabolism	-2.50479146127358	0.65433780148693	0.717111671873481	1/307	45/13181	91012	CERS5	1
KEGG_hsa04933	AGE-RAGE signaling pathway in diabetic complications	-4.09025578802598	0.658654969235498	0.720963782809136	2/307	96/13181	5603/596	MAPK13/BCL2	2
KEGG_hsa05160	Hepatitis C	-5.47463568921799	0.660475965635513	0.722441006465582	3/307	145/13181	5925/439996/317	RB1/IFIT1B/APAF1	3
KEGG_hsa00620	Pyruvate metabolism	-2.71297296935557	0.662416234415029	0.722441006465582	1/307	46/13181	127	ADH4	1
KEGG_hsa04390	Hippo signaling pathway	-4.66990307405699	0.665033258074333	0.724416025765011	3/307	146/13181	1739/60485/84552	DLG1/SAV1/PARD6G	3
KEGG_hsa00240	Pyrimidine metabolism	-2.60344873970846	0.685539716618846	0.740717650967146	1/307	49/13181	5167	ENPP1	1
KEGG_hsa04979	Cholesterol metabolism	-2.65973611064716	0.685539716618846	0.740717650967146	1/307	49/13181	4018	LPA	1
KEGG_hsa05017	Spinocerebellar ataxia	-4.28822323202818	0.685768270331601	0.740717650967146	2/307	101/13181	3710/5649	ITPR3/RELN	2
KEGG_hsa04934	Cushing syndrome	-5.19437237661888	0.691443859865824	0.746318257559602	3/307	152/13181	3710/779/5925	ITPR3/CACNA1S/RB1	3
KEGG_hsa03018	RNA degradation	-2.68639310380018	0.692891171614126	0.746318257559602	1/307	50/13181	9652	TTC37	1
KEGG_hsa04613	Neutrophil extracellular trap formation	-4.49580744840162	0.706169399159223	0.757068614853203	2/307	105/13181	7099/5603	TLR4/MAPK13	2
KEGG_hsa04340	Hedgehog signaling pathway	-2.51863122763248	0.707084114317643	0.757068614853203	1/307	52/13181	596	BCL2	1
KEGG_hsa00140	Steroid hormone biosynthesis	-2.68076725513855	0.713933468945145	0.761981247931952	1/307	53/13181	79799	UGT2A3	1
KEGG_hsa04724	Glutamatergic synapse	-4.56194910059016	0.715950419346434	0.763529402910596	2/307	107/13181	3710/6507	ITPR3/SLC1A3	2
KEGG_hsa04670	Leukocyte transendothelial migration	-4.1221576176741	0.725457286606216	0.769998072731912	2/307	109/13181	5603/6093	MAPK13/ROCK1	2
KEGG_hsa04726	Serotonergic synapse	-4.15779053074526	0.725457286606216	0.769998072731912	2/307	109/13181	3710/779	ITPR3/CACNA1S	2
KEGG_hsa04919	Thyroid hormone signaling pathway	-4.11424968772445	0.725457286606216	0.769998072731912	2/307	109/13181	6257/23389	RXRB/MED13L	2
KEGG_hsa00590	Arachidonic acid metabolism	-2.27390186641832	0.727156933670419	0.769998072731912	1/307	55/13181	80142	PTGES2	1
KEGG_hsa05204	Chemical carcinogenesis	-2.68076725513855	0.727156933670419	0.769998072731912	1/307	55/13181	79799	UGT2A3	1
KEGG_hsa04370	VEGF signaling pathway	-2.87849364175243	0.733538376711953	0.775841296043714	1/307	56/13181	5603	MAPK13	1
KEGG_hsa04330	Notch signaling pathway	-3.05006526093605	0.739771040967148	0.779375821198683	1/307	57/13181	23385	NCSTN	1
KEGG_hsa04730	Long-term depression	-3.18843192320265	0.739771040967148	0.779375821198683	1/307	57/13181	3710	ITPR3	1
KEGG_hsa04213	Longevity regulating pathway	-4.34063572413182	0.745858384035045	0.784562701271355	1/307	58/13181	5562	PRKAA1	1
KEGG_hsa05120	Epithelial cell signaling in Helicobacter pylori infection	-2.87849364175243	0.745858384035045	0.784562701271355	1/307	58/13181	5603	MAPK13	1
KEGG_hsa00010	Glycolysis / Gluconeogenesis	-2.71297296935557	0.751803783417903	0.789265015489279	1/307	59/13181	127	ADH4	1
KEGG_hsa04137	Mitophagy	-3.36596039750666	0.768820931569828	0.803388074229557	1/307	62/13181	10370	CITED2	1
KEGG_hsa05100	Bacterial invasion of epithelial cells	-2.56540121679177	0.774230793145258	0.806540269829836	1/307	63/13181	8936	WASF1	1
KEGG_hsa05221	Acute myeloid leukemia	-4.89767780170851	0.774230793145258	0.806540269829836	1/307	63/13181	861	RUNX1	1
KEGG_hsa00983	Drug metabolism	-2.68076725513855	0.779514460358584	0.809541981944045	1/307	64/13181	79799	UGT2A3	1
KEGG_hsa01230	Biosynthesis of amino acids	-2.25882545267613	0.779514460358584	0.809541981944045	1/307	64/13181	1491	CTH	1
KEGG_hsa04622	RIG-I-like receptor signaling pathway	-2.87849364175243	0.779514460358584	0.809541981944045	1/307	64/13181	5603	MAPK13	1
KEGG_hsa04068	FoxO signaling pathway	-5.47107698782623	0.780889116460432	0.810657319205747	2/307	122/13181	5603/5562	MAPK13/PRKAA1	2
KEGG_hsa04062	Chemokine signaling pathway	-4.69230021600659	0.781469518252194	0.810947583220907	3/307	176/13181	3718/6373/6093	JAK3/CXCL11/ROCK1	3
KEGG_hsa04720	Long-term potentiation	-3.18843192320265	0.784674867514939	0.812755662834989	1/307	65/13181	3710	ITPR3	1
KEGG_hsa04142	Lysosome	-5.233790002171	0.78471921007399	0.812755662834989	2/307	123/13181	27074/3482	LAMP3/IGF2R	2
KEGG_hsa04728	Dopaminergic synapse	-4.59786979329393	0.792203648256684	0.82019241002305	2/307	125/13181	3710/5603	ITPR3/MAPK13	2
KEGG_hsa05230	Central carbon metabolism in cancer	-2.41372563552681	0.794637300394889	0.822080645381665	1/307	67/13181	5156	PDGFRA	1
KEGG_hsa04926	Relaxin signaling pathway	-3.83674354260068	0.795859295413538	0.823029022031031	2/307	126/13181	5603/6019	MAPK13/RLN2	2
KEGG_hsa04371	Apelin signaling pathway	-5.70596628172115	0.806487791281442	0.83146886626951	2/307	129/13181	3710/5562	ITPR3/PRKAA1	2
KEGG_hsa04915	Estrogen signaling pathway	-4.32514508192091	0.81329796317093	0.835932637708283	2/307	131/13181	3710/596	ITPR3/BCL2	2
KEGG_hsa04140	Autophagy	-5.19835227645321	0.816622364636358	0.838710055260808	2/307	132/13181	596/5562	BCL2/PRKAA1	2
KEGG_hsa05212	Pancreatic cancer	-2.57462628526921	0.817579023852773	0.838734036646529	1/307	72/13181	5925	RB1	1
KEGG_hsa04918	Thyroid hormone synthesis	-3.18843192320265	0.826023536055813	0.845408980819567	1/307	74/13181	3710	ITPR3	1
KEGG_hsa04550	Signaling pathways regulating pluripotency of stem cells	-3.98611927375452	0.826280661891527	0.845408980819567	2/307	135/13181	3718/5603	JAK3/MAPK13	2
KEGG_hsa04914	Progesterone-mediated oocyte maturation	-2.87849364175243	0.830098516938614	0.848027889983518	1/307	75/13181	5603	MAPK13	1
KEGG_hsa04971	Gastric acid secretion	-3.18843192320265	0.830098516938614	0.848027889983518	1/307	75/13181	3710	ITPR3	1
KEGG_hsa04662	B cell receptor signaling pathway	-2.61060480780367	0.834078354822014	0.851126133459557	1/307	76/13181	10892	MALT1	1
KEGG_hsa04012	ErbB signaling pathway	-3.37024760049466	0.849089799237587	0.863177261970035	1/307	80/13181	27	ABL2	1
KEGG_hsa04610	Complement and coagulation cascades	-2.26791085340931	0.849089799237587	0.863177261970035	1/307	80/13181	1604	CD55	1
KEGG_hsa04110	Cell cycle	-2.57462628526921	0.852626127123554	0.866119080152638	1/307	81/13181	5925	RB1	1
KEGG_hsa05210	Colorectal cancer	-2.51863122763248	0.852626127123554	0.866119080152638	1/307	81/13181	596	BCL2	1
KEGG_hsa04976	Bile secretion	-2.68076725513855	0.859452893371492	0.872396461042749	1/307	83/13181	79799	UGT2A3	1
KEGG_hsa04350	TGF-beta signaling pathway	-2.56072594422129	0.862747133845988	0.874094803776319	1/307	84/13181	6093	ROCK1	1
KEGG_hsa04666	Fc gamma R-mediated phagocytosis	-2.56540121679177	0.862747133845988	0.874094803776319	1/307	84/13181	8936	WASF1	1
KEGG_hsa04727	GABAergic synapse	-2.29780557345236	0.862747133845988	0.874094803776319	1/307	84/13181	779	CACNA1S	1
KEGG_hsa04211	Longevity regulating pathway	-4.34063572413182	0.872175181409836	0.882651760165509	1/307	87/13181	5562	PRKAA1	1
KEGG_hsa05225	Hepatocellular carcinoma	-4.46692175823077	0.881999029597527	0.890587784192859	2/307	156/13181	5925/3082	RB1/HGF	2
KEGG_hsa04713	Circadian entrainment	-3.18843192320265	0.88647569205995	0.894103429028666	1/307	92/13181	3710	ITPR3	1
KEGG_hsa04916	Melanogenesis	-2.85611684736861	0.906113034060613	0.911522664114706	1/307	100/13181	4254	KITLG	1
KEGG_hsa04150	mTOR signaling pathway	-4.34063572413182	0.960116204600003	0.961542826003569	1/307	136/13181	5562	PRKAA1	1
KEGG_hsa05224	Breast cancer	-2.57462628526921	0.966241763456304	0.966600294722893	1/307	143/13181	5925	RB1	1
